iX Biopharma Ltd. | Ownership
Companies that own iX Biopharma Ltd.
Pheim Asset Management Sdn. Bhd.
5,141,597
0.8%
-444,549
1.83%
11/20/2017
Pheim Asset Management (Asia) Pte Ltd.
2,272,700
0.35%
0
2.29%
12/31/2017
| Address |
1 Kim Seng Promenade, No. 14-01
Singapore CE 237994
Singapore
|
|
Employees
|
- |
| Website |
http://www.ixbiopharma.com |
| Updated |
07/08/2019 |
| iX Biopharma Ltd. engages in the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, as well as male erectile dysfunction. It operates through the following segments: Specialty Pharmaceutical and Chemical Analysis. The Specialty Pharmaceutical segment manufactures and sells pharmaceutical products. |
